Anthropic Files for IPO: Sales Surge, Costs Mount and Spending Plans Top $500 Billion
Чтение займёт 1 минуту
Главное:
- Anthropic IPO is finally happening
- Price tag unknown, likely above $1.5T
- Revenue rockets, net loss spikes to $80B
Claude developer is preparing for a possible November debut, giving investors a closer look at extraordinary growth. But wait, there’s more.
🔔 A blockbuster listing takes shape
- Anthropic made its IPO filing public Monday, applying to list on the Nasdaq under the ticker ANT. Goldman Sachs and Morgan Stanley are leading the offering.
- The startup AI company has yet to announce its share price or offering size, so the filing opens the process without settling its most important question: what investors will pay.
- The company is targeting a debut during the week of November 16, according to The Wall Street Journal, although timing could change. The offering could raise $100 billion or more at a valuation between $1.5 trillion and $2 trillion.
- The growth helps explain the anticipation. First-half revenue reached $16.3 billion, up from roughly $1.2 billion a year earlier. Anthropic nevertheless warns that its growth rate could slow and that profitability may prove difficult to sustain.
💰 The loss needs some unpacking
- Anthropic’s $80.7 billion first-half net loss included a $72.4 billion accounting charge related to financing agreements. The headline loss does not mean the company spent $80.7 billion more cash than it received.
- Its operating loss narrowed to $693 million, while adjusted operating income reached a positive $1.62 billion.
- Operating results provide a clearer view of the underlying business, although adjusted figures exclude certain expenses.
⚖️ Investors get growth and constraints
- The filing also describes risks from powerful AI, including misuse, manipulation and behavior resembling blackmail.
- Public ownership will come with limited influence over control. A special share held through an entity organized by Anthropic’s seven co-founders will carry 50.1% of voting power.
- Its Long-Term Benefit Trust generally retains the ability to appoint a board majority. Buying into the company therefore means accepting an unusually concentrated governance structure.